GSK-2256098 (hydrochloride)
GSK-2256098 hydrochloride is a focal adhesion kinase (FAK) inhibitor that exhibits potential antiangiogenic and antineoplastic activities. GSK-2256098 hydrochloride targets FAK to inhibit tumor cell growth by regulating cell adhesion, migration, proliferation, and survival.
Product Specifications
CAS Number
[1416771-10-2]
UNSPSC
12352005
Target
Apoptosis; FAK
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk-2256098-hydrochloride.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NOC)C1=CC=CC=C1NC2=CC(NC3=CC(C)=NN3C(C)C)=NC=C2Cl.Cl
Molecular Formula
C20H24Cl2N6O2
Molecular Weight
451.35
References & Citations
[1]Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Browse additional items from our catalog
![2,5-Anhydro-1,3,4-trideoxy-2-C- (2,4-difluorophenyl) -4-[[4-[4-[4-[1- (1-ethylpropyl) -1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1- (1H-1,2,4-triazol-1-yl) -D-threo-pentitol](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
2,5-Anhydro-1,3,4-trideoxy-2-C- (2,4-difluorophenyl) -4-[[4-[4-[4-[1- (1-ethylpropyl) -1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1- (1H-1,2,4-triazol-1-yl) -D-threo-pentitol
YBX1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
GABRA3 (Gamma-aminobutyric Acid Receptor Subunit alpha-3, GABA (A) Receptor Subunit alpha-3) (HRP)
